Skip to content

A randomised, single-blind, two-limbed, parallel-group study to compare the effectiveness of 'individualised traditional Korean acupuncture' with one of 'standardised acupuncture' in Korean patients with knee osteoarthritis

A randomised, single-blind, two-limbed, parallel-group study to compare the effectiveness of 'individualised traditional Korean acupuncture' with one of 'standardised acupuncture' in Korean patients with knee osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN40706107
Enrollment
50
Registered
2007-01-16
Start date
2006-05-01
Completion date
Unknown
Last updated
2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis Musculoskeletal Diseases Arthritis

Interventions

Arm A: Individualised traditional Korean acupuncture Arm B: Standardised acupuncture

Sponsors

Korea Institute of Oriental Medicine (South Korea)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. At least 40 years old 2. Current symptoms of chronic (six months), stable pain and/or stiffness in one or both knees during weight-bearing activities 3. Knee pain due to OA rated more than 4 cm on a 10 cm Visual Analogue Scale (VAS) in one or both knees 4. Morning stiffness of knee for less than or equal to 30 minutes 5. Mild joint space narrowing (more than or equal to 2 mm remaining) in knee AnteroPosterior (AP) standing or Rosenberg view

Exclusion criteria

Exclusion criteria: 1. Inflammatory, metabolic, or neuropathic arthropathies 2. Trauma or surgery to the knee(s) which is causing pain or functional problems within six months prior to the enrolment period 3. Suspicious meniscus injury by physical examination 4. Pain emanating more from back or hip than from knee, interfering with patient knee assessment 5. Any condition which severely limits local ambulation, such as amputation or stroke 6. History of or evidence of active rheumatologic disease, severe peripheral neuropathy, clinically evident cardiac or respiratory disease that interferes with functional status, or other serious diseases, including psychiatric disorders 7. Autoimmune disease, Systemic Lupus Erythematosus (SLE), psoriatic arthritis, active (redness, swelling, fever, etc.) gout or pseudo-gout within six months prior to screening 8. History of prolotherapy, or injection of hyaluronic acid or cortisone within the last three months 9. Inability to stop anti-inflammatory medication or Non Steroidal Anti-Inflammatory Drug (NSAID) such as acetaminophen for the entire study 10. Bleeding disorders that might contraindicate acupuncture 11. Pension or disability benefits

Design outcomes

Primary

MeasureTime frame
Pain rating based on a 100 mm VAS

Secondary

MeasureTime frame
1. Western Ontario MacMaster Questionnaire (WOMAC) Scale 2. Quality of Life (Short Form health survey [SF-36]) 3. Lequesne Functional Index (LFI) score 4. Physical function was evaluated by the Korean version of Health Assessment Questionnaire (KHAQ)

Countries

Korea, South

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026